Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 14/20 | 0.45 |
| ▸ | CYP24A1 | Q07973 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5057736 | 1.00 | KIF11 (0.45) | KIF11CYP24A1CA12CA1CA9 | |
| SCHEMBL4512510 | 0.92 | KIF11 (0.48) | KIF11CYP24A1CA12CA1CA9 | |
| SCHEMBL4526888 | 0.92 | KIF11 (0.48) | KIF11CYP24A1CA12CA1CA9 | |
| SCHEMBL357884 | 0.84 | KIF11 (0.45) | KIF11ALDH1A1 | |
| SCHEMBL4303777 | 0.82 | TK1 (0.43) | KIF11CYP24A1CA12CA1CA9 | |
| SCHEMBL4013278 | 0.80 | TK2 (0.42) | KIF11CYP24A1CA12CA1CA9 | |
| SCHEMBL20120297 | 0.79 | ALDH1A1 (0.47) | CYP24A1CA12CA1CA9CYP3A4 | |
| SCHEMBL12390525 | 0.79 | KIF11 (0.47) | KIF11 | |
| SCHEMBL9999946 | 0.79 | KIF11 (0.47) | KIF11 | |
| Biphenyl SCHEMBL17044634 | 0.79 | CYP24A1 (0.44) | CYP24A1CA12CA1CA9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325262-A1 | Immobilization of biological molecules onto surfaces coated with monolayers | SURFACE LOGIX, INC. | 2009-12-31 | — | — | US | disclosed |
| US-7439056-B2 | Peelable and resealable devices for arraying materials | SURFACE LOGIX INC. (US) | 2008-10-21 | — | — | US | disclosed |
| US-7371563-B2 | Peelable and resealable devices for biochemical assays | SURFACE LOGIX, INC. (US) | 2008-05-13 | — | — | US | disclosed |
| US-7001740-B2 | Methods of arraying biological materials using peelable and resealable devices | SURFACE LOGIX, INC. (US) | 2006-02-21 | — | — | US | disclosed |
| US-20050250097-A1 | METHODS OF ARRAYING BIOLOGICAL MATERIALS USING PEELABLE AND RESEALABLE DEVICES | SURFACE LOGIX, LLC | 2005-11-10 | — | — | US | disclosed |
| US-20050100974-A1 | METHODS OF DETECTING IMMOBILIZED BIOMOLECULES | SURFACE LOGIX, LLC | 2005-05-12 | — | — | US | disclosed |
| US-6803205-B2 | MONITORING ENZYME ACTIVITY IN SAMPLE; OBTAIN ENZYME SAMPLE, INSERT INTO RESEALABLE APPARATUS, EXPOSE TO SUBSTRATE, MEASURE ENZYME ACTIVITY | SURFACE LOGIX, INC. | 2004-10-12 | — | — | US | disclosed |
| US-20030073228-A1 | Peelable and resealable devices for arraying materials | SURFACE LOGIX, LLC | 2003-04-17 | — | — | US | disclosed |
| US-20030032076-A1 | Methods of measuring enzyme activity using peelable and resealable devices | SURFACE LOGIX, LLC | 2003-02-13 | — | — | US | disclosed |
| US-20030032046-A1 | Peelable and resealable devices for biochemical assays | SURFACE LOGIX, LLC | 2003-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325262-A1 | Immobilization of biological molecules onto surfaces coated with monolayers | EPCAM, ICAM1, MB | KIF11 3822/4885CYP24A1 3520/4885CA12 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.